ArticlePediatric research2026
Comparing procalcitonin and C-reactive protein levels in very low birth weight infants with sepsis.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparison of efficacy of procalcitonin (PCT) and serum C-reactive protein (CRP) as biochemical markers of sepsis in pediatric intensive care unit (ICU).Pakistan journal of medical sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhile C-reactive protein (CRP) is a commonly used sepsis biomarker in neonates, studies in older patients propose procalcitonin (PCT) as potentially superior due to earlier rise in response to bacterial infection and shorter half-life.
methodsWe conducted a prospective cohort study of VLBW infants undergoing sepsis evaluations at a level IV neonatal intensive care unit (NICU) and combined the analysis with a retrospective data review from a different level III NICU. We adjusted all analyses for study site to account for potential heterogeneity. Two blood samples for each biomarker obtained within a 24-h period were analyzed. Diagnostic accuracy was assessed by sensitivity, specificity, predictive values, likelihood ratios, and the area under the receiver operating characteristic (ROC) curve (AUC).
resultsAt literature-defined cut-offs, PCT demonstrated higher sensitivity, but lower specificity for sepsis compared to CRP. Using ROC-optimized cut-offs, CRP showed increased specificity (85%) but lower sensitivity (48%), whereas PCT maintained relatively high sensitivity (73%) but even lower specificity (60%). In multivariable modeling, only CRP was significantly associated with sepsis. Correlation between the biomarkers was weak.
conclusionsPCT did not outperform CRP as a sepsis biomarker. CRP was more specific and remained the stronger independent predictor of sepsis. IMPACT: Procalcitonin (PCT) shows higher sensitivity, but lower specificity compared to C-reactive protein (CRP) in very low birth weight infants with sepsis. CRP emerges as the stronger independent predictor of sepsis in multivariable models. This study constitutes one of the largest United States cohorts directly comparing CRP and PCT in this high-risk group.
Identifiers
41807697What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.